From Evidence to Theory: Neo-Liberal Corporate Bias as a Framework for Understanding UK Pharmaceuticals Regulation – Response to Alison Edgley-Reference-Cited by-同舟云学术

From Evidence to Theory: Neo-Liberal Corporate Bias as a Framework for Understanding UK Pharmaceuticals Regulation – Response to Alison Edgley

Published:2007-04-25 Issue:2 Volume:5 Page:161-175
ISSN:1477-8211
Container-title:Social Theory & Health
language:en
Short-container-title:Soc Theory Health

Author:

Abraham John

Publisher

Springer Science and Business Media LLC

Subject

Sociology and Political Science,Health(social science)

Link

http://link.springer.com/content/pdf/10.1057/palgrave.sth.8700097.pdf

Reference12 articles.

1. Abraham J (1995). Science, Politics and the Pharmaceutical Industry: Controversy and Bias in Drug Regulation. UCL/St Martins Press: London and New York.

2. Abraham J (2002a). The pharmaceutical industry as political player. Lancet 360: 1498–1502.

3. Abraham J (2002b). Making regulation responsive to commercial interests: streamlining drug industry watchdogs. British Medical Journal 325: 1164–1169.

4. Abraham J, Davis C (2005). A comparative analysis of drug safety withdrawals in the UK and the US (1971–1992): implications for current regulatory thinking and policy. Social Science & Medicine 61: 881–892.

5. Abraham J, Lewis G (2000). Regulating Medicines in Europe: Competition, Expertise and Public Health. Routledge: London and New York.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Divergent spender: State‐societal and meso‐organisational mechanisms in the containment of public spending on pharmaceuticals in a liberal capitalist democracy;Sociology of Health & Illness;2021-07

2. Public-private partnerships and the politics of alcohol policy in England: the Coalition Government’s Public Health ‘Responsibility Deal’;BMC Public Health;2019-11-08

3. Governing drug reimbursement policy in Poland: The role of the state, civil society, and the private sector;Theory and Society;2017-11-03

4. Biobanks in Oral Health: Promises and Implications of Post-Neoliberal Science and Innovation;OMICS: A Journal of Integrative Biology;2016-01

5. The drugs don't sell: DIY heart health and the over-the-counter statin experience;Social Science & Medicine;2015-04